Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial

被引：0
|
作者：
Louise Thorlacius-Ussing
Christian Østergaard Andersen
Niels Frimodt-Møller
Inge Jenny Dahl Knudsen
Jens Lundgren
Thomas Lars Benfield
机构：
[1] Copenhagen University Hospital,Department of Infectious Diseases, Hvidovre Hospital
[2] Copenhagen University Hospital,Department of Clinical Microbiology, Hvidovre Hospital
[3] Rigshospitalet,Department of Clinical Microbiology
[4] Copenhagen University Hospital,Department of Infectious Diseases, Rigshospitalet
[5] Copenhagen University Hospital,undefined
来源：
Trials | / 20卷
关键词：
Randomized controlled trial; bacteremia; Bloodstream infection; Treatment duration; Short-course therapy; Uncomplicated ; bacteremia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial
    Thorlacius-Ussing, Louise
    Andersen, Christian Ostergaard
    Frimodt-Moller, Niels
    Knudsen, Inge Jenny Dahl
    Lundgren, Jens
    Benfield, Thomas Lars
    TRIALS, 2019, 20 (1)
  • [2] Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
    Yahav, Dafna
    Franceschini, Erica
    Koppel, Fidi
    Turjeman, Adi
    Babich, Tanya
    Bitterman, Roni
    Neuberger, Ami
    Ghanem-Zoubi, Nesrin
    Santoro, Antonella
    Eliakim-Raz, Noa
    Pertzov, Barak
    Steinmetz, Tali
    Stern, Anat
    Dickstein, Yaakov
    Maroun, Elias
    Zayyad, Hiba
    Bishara, Jihad
    Alon, Danny
    Edel, Yonatan
    Goldberg, Elad
    Venturelli, Claudia
    Mussini, Cristina
    Leibovici, Leonard
    Paul, Mical
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (07) : 1091 - 1098
  • [3] Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial
    Cheng, Matthew P.
    Lawandi, Alexander
    Butler-Laporte, Guillaume
    Paquette, Katryn
    Lee, Todd C.
    TRIALS, 2018, 19
  • [4] Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial
    Matthew P. Cheng
    Alexander Lawandi
    Guillaume Butler-Laporte
    Katryn Paquette
    Todd C. Lee
    Trials, 19
  • [5] Retrospective study to investigate appropriate duration of antibiotic treatment for uncomplicated Staphylococcus aureus bacteremia in patients with immunodeficiency
    Shibata, Yuichi
    Asai, Nobuhiro
    Hirai, Jun
    Mori, Nobuaki
    Hagihara, Mao
    Mikamo, Hiroshige
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (11) : 1141 - 1146
  • [6] Adjunctive Daptomycin in the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Randomized, Controlled Trial
    Cheng, Matthew P.
    Lawandi, Alexander
    Butler-Laporte, Guillaume
    De L'Etoile-Morel, Samuel
    Paquette, Katryn
    Lee, Todd C.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (09) : E196 - E203
  • [7] Does Adjunctive Clindamycin Have a Role in Staphylococcus aureus Bacteremia? A Protocol for the Adjunctive Treatment Domain of the Staphylococcus aureus Network Adaptive Platform (SNAP) Randomized Controlled Trial
    Anpalagan, Keerthi
    Dotel, Ravindra
    MacFadden, Derek R.
    Smith, Simon
    Voss, Lesley
    Petersiel, Neta
    Marks, Michael
    Marsh, Julie
    Mahar, Robert K.
    McGlothlin, Anna
    Lee, Todd C.
    Goodman, Anna
    Morpeth, Susan
    Davis, Joshua S.
    Tong, Steven Y. C.
    Bowen, Asha C.
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (03) : 626 - 634
  • [8] A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study
    Stryjewski, Martin E.
    Lentnek, Arnold
    O'Riordan, William
    Pullman, John
    Tambyah, Paul Anantharajah
    Miro, Jose M.
    Fowler, Vance G., Jr.
    Barriere, Steven L.
    Kitt, Michael M.
    Corey, G. Ralph
    BMC INFECTIOUS DISEASES, 2014, 14
  • [9] A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study
    Martin E Stryjewski
    Arnold Lentnek
    William O’Riordan
    John Pullman
    Paul Anantharajah Tambyah
    Jose M Miró
    Vance G Fowler Jr
    Steven L Barriere
    Michael M Kitt
    G Ralph Corey
    BMC Infectious Diseases, 14
  • [10] Treatment of acute uncomplicated cystitis with faropenem for 3 days versus 7 days: multicentre, randomized, open-label, controlled trial
    Hamasuna, Ryoichi
    Tanaka, Kazushi
    Hayami, Hiroshi
    Yasuda, Mitsuru
    Takahashi, Satoshi
    Kobayashi, Kanao
    Kiyota, Hiroshi
    Yamamoto, Shingo
    Arakawa, Soichi
    Matsumoto, Tetsuro
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (06) : 1675 - 1680
12345